Skyrizi 150 mg/mL

Skyrizi 150 mg/mL is a subcutaneous injection used for managing moderate to severe plaque psoriasis. This medication, containing risankizumab-rzaa, is designed to help reduce inflammation and improve skin condition. Learn more about Skyrizi 150 mg/mL uses and benefits.

Skyrizi 150 mg/mL is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. This medication works by targeting specific proteins in the body to reduce inflammation and slow down the overproduction of skin cells. People often ask, 'What is Skyrizi used for?' and the answer is that it is specifically formulated to help manage the symptoms of plaque psoriasis, including red, itchy, and scaly patches on the skin.

Common effects of Skyrizi 150 mg/mL may include reactions at the injection site, such as redness, itching, or swelling. Some users might experience upper respiratory infections, headache, or fatigue. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions.

Before using Skyrizi 150 mg/mL, inform your healthcare provider about any allergies or medical conditions you have. This medication should be used with caution in individuals with a history of infections or immune system disorders. Always follow the storage and handling instructions provided with the product to ensure its effectiveness and safety.

Skyrizi 150 mg/mL may interact with other medications, including those that affect the immune system. It's important to discuss all current medications with your healthcare provider to avoid potential interactions. Additionally, avoid alcohol while using this medication, as it may increase the risk of side effects.